Skip to content

Human Photoallergy Test

Human Photoallergy Test

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02751515
Enrollment
54
Registered
2016-04-26
Start date
2016-05-31
Completion date
2016-07-31
Last updated
2016-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sunscreening Agents

Brief summary

To evaluate the potential of a test material to produce a photoallergic response.

Interventions

0.05gm/ cm2 of the test article is applied directly to two sites on the skin and covered with the appropriate patch. 24 hours later, the patches are removed. The test sites are lightly wiped with a dry cloth/tissue and 3μl/ cm2 of test article is reapplied directly to the skin of the test site designated for irradiation, and lightly spread over the test site. 48 hours later the procedure is repeated to the same test sites. This process is repeated twice weekly for a total of six exposures.

One site is patched without treatment as control

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Be male or female between the ages of 18 and 60 inclusive * Be lightly pigmented (Fitzpatrick Skin Type I, II, III) * Have read and signed the written Informed Consent Form and have completed a Health Insurance Portability and Accountability (HIPAA) Authorization Form in conformance with 45CFR Parts 160 and 164 * Be in general good health as determined by the subject's medical history and in the discretion of the investigator

Exclusion criteria

* Have a visible sunburn * Have a history of sun hypersensitivity/photosensitivity or photosensitive dermatoses * Have a known hypersensitivity or allergy against any of the active and non-active ingredients of the investigational products * Subjects who are employees of the Contract Research Organization (CRO) and/or Bayer or is a household member of an employee

Design outcomes

Primary

MeasureTime frame
Intensity of skin reactions is evaluated by 5 point scaleUp to 72 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026